Additional studies using a mammalian two-hybrid system and ChIP indicate that 2MD is also more potent in promoting interaction with RXR and the coactivators SRC-1 and DRIP205. Finally, protease digestion studies revealed a unique VDR conformation in the presence of 2MD. These studies suggest that the molecular mechanism of 2MD potency is due to its ability to promote enhanced levels of specific DNA binding by the VDR and 
could suggest possible explanations for the tissue-and gene-selective actions of 2MD.
INTRODUCTION
The physiological actions of 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) 1 are mediated by the vitamin D receptor (VDR) (1) . This predominantly nuclear protein is a member of the steroid receptor gene family of transcription factors and functions like other nuclear receptors to regulate the expression of genes involved in a wide variety of cellular activities. The major role of 1,25(OH) 2 D 3 is to maintain calcium and phosphorus homeostasis through its direct actions on gene expression in the intestine, kidney and bone (2) . This hormone also regulates proliferation, differentiation, activity and survival of a number of cell types, many of which are not involved in mineral homeostasis (3) . The biological relevance of these latter actions remains to be determined, however, given the largely skeletal phenoptype associated with null mutations of the VDR gene in both humans and in mice (4, 5) . Ligand association with the VDR leads to rapid activation and subsequent accumulation of the receptor on vitamin D response elements (VDREs) located within the promoter regions of specific genes (1) . VDRE binding is facilitated by the retinoid X receptor (RXR) which functions both as a heterodimeric DNA binding partner as well as a participant in transactivation (6) . The role of RXR in VDR-mediated gene repression is unclear and appears to be somewhat controversial (7) . Regardless, these initial molecular actions of 1,25(OH) 2 D 3 and its receptor are essential to the subsequent alteration in the expression of genes involved in a variety of highly pleiotropic cellular responses.
A number of steroid hormone analogs, including those for 1,25(OH) 2 D 3 have been synthesized and characterized (8) . With respect to vitamin D 3 analogs, many of these are highly potent activators of gene transcription despite the fact that their affinities for VDR are not different from that of the native hormone. While enhanced potency can arise in vivo as a result of an analog's pharmacokinetic properties, recent studies in vitro have suggested that at least for some analogs increased potency may be due to their ability to induce unique VDR conformations that favor enhanced interaction with either RXR or coactivators such as SRC-1 or DRIP205 (9) (10) (11) . Interestingly, while altered receptor conformations are supported through proteolytic digestion studies in vitro, they are not supported by three-dimensional structural analyses (12, 13) . Other 1,25(OH) 2 D 3 analogs display disparate actions, exerting highly potent effects on cellular proliferation and differentiation or to suppress parathyroid hormone gene expression, yet demonstrating a restricted ability to induce calcium mobilization from bone or calcium uptake from the gut (14, 15) . Since increased serum calcium promotes soft tissue degeneration and other equally detrimental effects, compounds with a low hypercalcemic potential are highly desirable therapeutically. The underlying mechanism(s) for this selectivity is not known, but is likely to be complex given the diverse molecular mechanisms that drive bone resorption, intestinal absorption, and renal reabsorption of calcium.
2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D 3 (2MD) is a highly potent 1,25(OH) 2 D 3 analog that exhibits tissue-selective as well as gene-selective actions in vitro and in vivo (16, 17) . This compound binds to the VDR with a K d that is similar to that for 1,25(OH) 2 D 3 , although its interaction with serum vitamin D binding protein (DBP) is exceedingly weak (16 and DeLuca, H.F., unpublished). In vivo studies suggest that this analog appears to localize selectively to bone relative to intestine (16) .
2MD strongly induces calcium resorption from bone in vivo, an activity that is likely due to its ability to induce receptor activator of NF-κB ligand (RANKL) from supportive stromal cells and osteoblasts. RANKL is a key regulator of osteoclast formation, activity and survival (18, 19) , and is potently induced by both 1,25(OH) 2 D 3 and 2MD in cultured cells (17) . Interestingly, treatment of ovariectomized adult rats with low doses of 2MD leads to a dramatic increase in bone mineral density (BMD) in aged, ovariectomized rats (17) . While the mechanism of this dramatic anabolic activity of 2MD is not yet understood, in vitro studies suggest that 2MD exhibits an exceptionally potent and unique ability to enhance VDR-mediated osteoblast activity that leads to increased mineralization (17) . In this manuscript, we explore the underlying molecular basis for the increased potency of 2MD using osteoblast cell models. We find that 1,25(OH) 2 D 3 and 2MD bind equivalently to the VDR under serum-free conditions. Despite this, localization of the receptor to VDREs lying adjacent to 1,25(OH) 2 D 3 -inducible promoters in intact cells occurs at concentrations of 2MD that are much lower than that for 1,25(OH) 2 D 3 . VDR DNA-binding correlates directly with the ability of the two ligands to activate transcription. A 2MD-mediated increase in VDR DNA affinity may result from enhanced VDR interaction with RXR and with coactivators such as SRC-1 and DRIP205, both of which could enhance the stability of the VDR on DNA. (20, 21) . pcDNA-hVDR, phVDR-VP16 and pCH110-βgal have been also previously described (20, 22) . pcDNA-hVDR(R417A/R420A) was prepared from pcDNA-hVDR using the QuikChange site-directed mutagenesis kit from Stratagene (La Jolla, CA). The Gal4 (1-147) DNA-binding domain (DBD) fusion vectors pM-SRC-1NR (residues 621-765) and pM-GRIP-NR (residues 629-760) have also previously described (22, 23) . Gal4 (1-147) DBD fusion vector pBIND (Promega, Madison, WI) was used to create pBIND-mRXRα (residues 292-467) and pBINDhDRIP205NR (residues 527-970). pET-hVDR comprised of the full-length VDR containing a C-terminal 6xHis tag was constructed from the pET-29b vector obtained from Novagen (Darmstadt, Germany). pGEX-SRC-1NR (residues 621-765), pGEX-GRIP-NR (residues 629-760), pGEX-mRXRα (residues 203-467) and pGEX-DRIP205-NR (residues 527-970) were constructed using the pGEX parent plasmid obtained from Amersham (Piscataway, NJ).
MATERIALS AND METHODS

Reagents
Cell Culture-MC3T3-E1 cells and ST2 cells were cultured in α-MEM medium supplemented with 10% fetal bovine serum (FBS) from BioWhittaker (Walkerville, MD).
Vitamin D 3 ligands were added in ethanol (1% maximum final concentration).
Osteoclast Formation-Spleen cells were obtained from six-week-old C57B6 mice (Harlan-Sprague Dawley, Indianapolis, IN), treated with lysis buffer (155mM NH 4 Cl, 12mM NaHCO 3 , 1mM EDTA) and prepared as previously described (17) . Coculture assays were carried out by plating ST2 cells (5x10 4 /well) together with freshly isolated spleen cells (1x10 6 /well) in 48-well plates. Cells were cultured in phenol red-free α-MEM with 10% charcoal dextran-treated FBS in the presence or absence of indicated compounds and the medium replaced on day 4 and day 7. Cells were fixed and stained for tartrate-resistant acid phosphatase (TRAP) activity on day 8-10 as previously described (24) . Osteoclast number was determined by counting the total number of multinucleated (>3 nuclei), TRAP-positive cells/ well.
Transfection Analysis-MC3T3-E1 cells were seeded into 24-well plates at a density of 5x10 4 cells/well and transfected 16-24 hours later using Lipofectamine Plus as described (23) . Individual wells received 300 ng of DNA comprised of 250 ng of phOC-3900 luc or phCyp24-luc plasmid and 50 ng pCH110-β-gal. In the two-hybrid system, cells or 2MD-binding as previously described (25) . The difference between total binding and nonspecific binding represents specific VDR binding. Total cellular uptake of both ligands in these experiments was also assessed as described above.
GST Pulldown Assays-pET-VDR was transformed into BL21(DE3) codon Plus RIL cells (Stratagene, USA). Transformed cells were cultured with 100 uM IPTG at 23°C for 6 hr and soluble VDR protein purified to homogeneity from lysates using sequential Ni-NTA and SP-Sepharose column chromatography. Lysates from pGST-RXRα-, pGST-SRC-1NR-, pGST-GRIP-NR-and pGST-DRIP205-NR-transformed E. coli were incubated with glutathione-Sepharose 4B for 2 hrs at 4 C, and then washed extensively to prepare an immobilized GST fusion reagent of mRXRα, hSRC-1, hGRIP or hDRIP205. Purified VDR and immobilized GST fusion proteins were incubated with 10 -8 to 10 -12 M 1,25(OH) 2 D 3 or 2MD in GST-binding buffer (20mM Tris-HCl, pH 7.9, 180mM KCl, 0.2mM EDTA, 0.05% Nonidet P-40, 0.5mM PMSF, 1mM DTT) containing 1 mg/ml BSA for 30 min at RT. After 5 washes, dissolved samples were resolved by SDS-PAGE, transferred to PVDF membranes and subjected to Western blot analysis as previously described (20) using the anti-VDR monoclonal antibody 9A7 (26) .
Blots were visualized using the ECL method.
Chromatin Immunoprecipitation (ChIP) Assays-Chromatin immunoprecipitation was performed as described previously (27, 28) . Briefly, MC3T3-E1 cells were cultured in Precipitates were then washed sequentially and the cross-links reversed with a 6 hr incubation at 65°C in 1% SDS and 0.1M NaHCO 3 . DNA fragments were purified using Qiagen QIAquick Spin Kits (Valencia, CA) and subjected to PCR techniques using primers designed to amplify fragments of murine Cyp24 promoter region (-236 to -51) and murine OPN promoter region (-854 to -658). All PCR analyses for each primer set were carried out in a predetermined linear range of DNA amplification. PCR products were resolved on 2% agarose gels and visualized using ethidium bromide staining. trypsin (0.12 ug/sample) at RT for the indicated time periods as described (9) . Digestion was terminated with denaturing buffer, whereupon the samples were resolved by SDS-PAGE. Dried gels were subjected to autoradiography.
Protease Digestion Studies-
RESULTS
2MD is a 1,25(OH) 2 D 3 -Like Superagonist in Cell Culture-Previous studies revealed
that 2MD is a highly potent compound that exhibits both tissue-and gene-selectivity in vivo (16) . Several of these characteristics have also been demonstrated in cell culture (17) . For example, 2MD is at least 100-fold more active indicate that 2MD continues to exhibit an approximately two-log increase in potency (Fig. 3a) , revealing that its superagonist activity is not due to serum. Similar results were obtained with the hCyp24 promoter (data not shown). Interestingly, the level of transcription induced under serum-free conditions in 1 hr or less exposure to functionally equivalent levels of 1,25(OH) 2 D 3 (10 -7 M) and 2MD (10 -9 M) is at least 50% of that achieved following continual treatment with the two ligands for 24 hr in the presence of serum (Fig. 3b) . Irrespective of this, the data suggest that the potency of 2MD is not derived from its lack of interaction with serum components. although the difference does not seem able to account for the 2 log increase in potency.
Cellular Uptake of 1,25(OH) 2 D 3 and 2MD Does Not Determine Potency-
Despite this, the observation that virtually identical levels of both 1,25(OH) 2 D 3 and 2MD accumulate in cells in the absence of serum indicates that the increased potency of 2MD is not due to altered cellular uptake.
Binding of 1,25(OH) 2 D 3 and 2MD to the VDR is Similar In Intact Cells-Based upon
the above findings, we tested an alternative possibility that VDR might exhibit an with GST-GRIP were identical (data not shown). In the two-hybrid system, however, 2MD again manifested a two log increase in potency over 1,25(OH) 2 D 3 in promoting VDR interaction with both SRC-1 (Fig. 8b) and DRIP205 (Fig. 8c) and similar findings were observed with GRIP/SRC-2 (data not shown). ChIP analysis supported this finding. Thus, while 0.1 nM 1,25(OH) 2 D 3 was ineffectual, the same concentration of 2MD strongly induced association of not only VDR and RXR to the Cyp24 gene promoter, but SRC-1 as well (Fig. 8d) . These results support the idea that 2MD promotes DNA binding though enhanced formation of a complex that involves not only RXR but LxxLL-containing p160 and DRIP205 coactivators as well.
2MD Induces a Unique VDR Conformation-Enhanced interaction of VDR with either
RXR or SRC-1 seen in intact cells in response to 2MD is likely to be mediated through a unique receptor conformation. We therefore prepared in vitro translated full-length VDR and subjected it to limited proteolytic digestion using trypsin. Previous studies with the VDR (as well as other nuclear receptors) have revealed that ligand-specific cleavage products can be demonstrated following SDS-PAGE (9, 33). (Fig. 9a, see arrows) . This result indicates that the conformation of the VDR differs depending upon the nature of the activating ligand. We also examined the tryptic digestion pattern of a hVDR which contained mutations in helix 12 of VDR AF-2. These mutations do not alter hormone-binding activity, but completely abrogate its transcriptional capabilities (34) . More importantly, proteolytic cleavage products can be demonstrated more readily with this VDR product (35) . High concentrations of both 1,25(OH) 2 D 3 and 2MD protect this mutant VDR from complete degradation (Fig. 9b) . More importantly, while both the 34 and the 28 kDa bands are evident with the 1,25(OH) 2 D 3 -treated samples, it is the 28 and 32 kDa bands that are most apparent in the 2MD-treated samples. These data provides strong structural evidence that the VDR exhibits a conformation in the presence of 2MD that is different from that with 1,25(OH) 2 D 3 .
DISCUSSION
2MD is a 1,25(OH) 2 D 3 analog in which the 20-carbon methyl group resides in
the S rather than the normal R configuration and a methylene group is located at carbon 2 rather than carbon 19 (16) . Like 1,25(OH) 2 D 3 , 2MD displays an affinity (K d ) for the VDR of ~1x10 -10 M, although its affinity for serum DBP is weak. These characteristics are likely to influence its pharmacokinetic properties and thus its actions in vivo. Biologically, 2MD is an extremely potent analog with significant anabolic actions in bone both in vivo and in vitro (16, 17) . These observations suggest that 2MD may be both tissue-and cell-specific in its actions. In this report, we focused upon the molecular mechanisms that underlie the enhanced potency of 2MD. This potency is Additional results also suggested a hypothesis that (20S) analog-induced coactivator interactions can enhance VDR DNA-binding and/or alter transactivation due to differences in receptor-ligand contacts within the LBD of the VDR. Freedman and colleagues were unable to confirm enhanced DNA binding and RXR interaction with VDR in vitro, but did demonstrate increased interaction with the coactivator DRIP205 (10) . This interaction appeared to increase the extent of activity in a cell-free transcriptional assay, although this system utilized non-chromatin templates that are to a large degree independent of hormonal regulation. It is unclear at present whether either of the above observations is correct, but they do indicate the difficulties of relying exclusively on biochemical interaction assays in vitro. Accordingly, we focused upon VDR complex formation on specific chromatin DNA in intact cells using ChIP assays.
We also evaluated the interaction of the VDR with its heterodimeric partner RXR as well as with potential facilitators of transactivation such as SRC-1 and DRIP205 using a mammalian two-hybrid system. Tryptic digestion of nuclear receptors has resulted in specific, ligand-dependent proteolytic patterns indicative of different receptor conformations (39, 40) . That these conformational differences exist with various ligands have been substantiated particularly well for the ER in X-ray diffractions studies (41, 42) . We observed such an altered pattern of digestion of the VDR, suggesting that 2MD promotes a receptor conformation different from that with 1,25(OH) 2 D 3 . This conformation was most evident when a form of the VDR that contained mutations in two of the residues responsible for the formation of the transactivation helix-12 was examined. These patterns did not reveal a difference in dose response between the two ligands, however, suggesting that potency differences are manifested only in the cell. Interestingly, the pattern of tryptic digestion was (45) . Regardless of the mechanism, it is clear that 2MD promotes enhanced affinity of the VDR for multiple components.
2MD is both tissue-as well as gene-selective, eliciting preferential activity in bone relative to the gut and stimulating bone formation that is not normally associated with1,25(OH) 2 D 3 or its analogs (16) . Why bone is a focal point of 2MD action in vivo is unknown currently, although evidence suggests that its anabolic activity may be due to its ability to promote osteoblast mineralization in vitro (17) . Many vitamin D analogs appear to exhibit characteristics of tissue and/or gene selectivity. Perhaps most notable is the inability of many analogs to provoke calcium homeostatic actions in the intestine, bone and kidney that lead to an elevation in serum calcium levels while simultaneously modulating cellular events such as proliferation and differentiation or regulating the expression of specific genes (46) . The physiologic basis for this selectivity is not understood; it may be pharmacokinetic in some cases (47) and mechanistic in others (9, 10, 33) . The mechanistic basis for selectivity could involve many aspect of VDR action. Many VDREs, for example, differ in structure from canonical direct repeats, and may well influence VDR binding and coactivator recruitment (48) . This has not been proven, however. In addition, VDREs are often located immediately adjacent to binding sites for other transcription factors, suggesting the possibility of ligand-dependent selectivity for protein-protein interactions that could involve not only the adjacent transcription factors but coactivators or repressors as well (49, 50) . With respect to the comodulator class of transcription factors, many have been identified (51) . They differ in concentration from cell to cell, are often promoter-specific in their actions, and their individual activities are modulated through diverse signaling pathway (51, 52) . Thus, ligand-selective recruitment of these coregulators could also occur, providing additional mechanisms of cell-and gene-selectivity. Thus, while our findings focus primarily on the potency of 2MD, they may well provide avenues to explore additional interesting features of this analog's actions.
In conclusion, we have demonstrated that the potency of 2MD is due to its ability to promote increased affinity of the VDR for specific DNA. Whether this increase is due to enhanced binding or increased stability of the transcriptional complex remains to be determined. Nevertheless, these features of 2MD action may provide hints as to how 1,25(OH) 2 D 3 analogs such as 2MD might exert tissue-and gene-selective actions in vivo. Future studies focus on these biological properties of 2MD. 
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